selected publications
-
academic article
- Long-Term Dementia Risk in Parkinson Disease.. Neurology. 103:-. 2024
- Genetic and phenotypic characterization of Parkinson's disease at the clinic-wide level.. NPJ Parkinson's disease. 10:-. 2024
- Epigenetic age and socioeconomic status contribute to racial disparities in cognitive and functional aging between Black and White older Americans.. medRxiv. 2023
- Psychometric Properties of the Clinical Dementia Rating Scale Sum of Boxes in Parkinson's Disease.. Journal of Parkinson's disease. 11:737-745. 2021
- Trends in oral anticoagulant co-prescription with antiepileptic drugs among adults with epilepsy, 2010-2018.. Epilepsy & behavior : E&B. -. 2020
- Subjective Cognitive Complaint in Parkinson's Disease Patients With Normal Cognition: Canary in the Coal Mine?. Movement disorders : official journal of the Movement Disorder Society. 35:1618-1625. 2020
- Pimavanserin versus quetiapine for the treatment of psychosis in Parkinson's disease and dementia with Lewy bodies.. Parkinsonism & related disorders. 119-124. 2019
- Cognitive Functional Abilities in Parkinson's Disease: Agreement Between Patients and Informants.. Movement disorders clinical practice. 6:440-445. 2019
- White matter hyperintensities in vascular contributions to cognitive impairment and dementia (VCID): Knowledge gaps and opportunities.. Alzheimer's & dementia (New York, N. Y.). 107-117. 2019
- The Kaplan-Meier Method for Estimating and Comparing Proportions in a Randomized Controlled Trial with Dropouts.. Biostatistics & Epidemiology. 2:23-33. 2017
- APOE, thought disorder, and SPARE-AD predict cognitive decline in established Parkinson's disease.. Movement disorders : official journal of the Movement Disorder Society. 33:289-297. 2017
- Vitamin D in the Parkinson Associated Risk Syndrome (PARS) study.. Movement Disorders. 32:1636-1640. 2017
- Neuropsychological Subgroups in Non-Demented Parkinson's Disease: A Latent Class Analysis.. Journal of Parkinson's disease. 7:385-395. 2017
- Statins and Cognition in Parkinson's Disease.. Journal of Parkinson's disease. 7:661-667. 2017
- Development and Validation of the Parkinson's Disease Medication Beliefs Scale (PD-Rx).. Journal of Parkinson's disease. 6:383-92. 2016
- The Penn Parkinson's Daily Activities Questionnaire-15: Psychometric properties of a brief assessment of cognitive instrumental activities of daily living in Parkinson's disease.. Parkinsonism & related disorders. 21-6. 2016
- Longitudinal study of normal cognition in Parkinson disease.. Neurology. 85:1276-82. 2015
- Development and initial testing of the Penn Parkinson's Daily Activities Questionnaire.. Movement disorders : official journal of the Movement Disorder Society. 31:126-34. 2015
- Assessing treatment effects with surrogate survival outcomes using an internal validation subsample.. Clinical trials (London, England). 12:333-41. 2015
- Nonparametric discrete survival function estimation with uncertain endpoints using an internal validation subsample.. Biometrics. 71:772-81. 2015
- Occupational attainment influences survival in autopsy-confirmed frontotemporal degeneration.. Neurology. 84:2070-5. 2015
- Rhodiola rosea versus sertraline for major depressive disorder: A randomized placebo-controlled trial.. Phytomedicine : international journal of phytotherapy and phytopharmacology. 22:394-9. 2015
- Electroacupuncture for fatigue, sleep, and psychological distress in breast cancer patients with aromatase inhibitor-related arthralgia: a randomized trial.. Cancer. 120:3744-51. 2014
- Integration and relative value of biomarkers for prediction of MCI to AD progression: spatial patterns of brain atrophy, cognitive scores, APOE genotype and CSF biomarkers.. NeuroImage. Clinical. 164-73. 2013
- Frequency and clinicopathological characteristics of presenilin 1 Gly206Ala mutation in Puerto Rican Hispanics with dementia.. Journal of Alzheimer's disease : JAD. 33:1089-95. 2013
- Genetic influences on cognitive decline in Parkinson's disease.. Movement disorders : official journal of the Movement Disorder Society. 27:512-8. 2012
- Ethnoracial differences in the clinical characteristics of Alzheimer's disease at initial presentation at an urban Alzheimer's disease center.. The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry. 19:430-9. 2011